Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPain ManagementPriority Health Neuroablation Coverage Update: Pri…
    Ask Trek AI about this page
    Modifiedpriority healthPolicy 91647

    Neuroablation for Pain Management

    Customize your policy alerts

    Sign up for priority health Policy 91647 alerts

    Get alerted when Policy 91647 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity, limitations, and exclusions for neuroablative procedures used to treat pain for Priority Health members; applies to providers requesting coverage determinations.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    Payerpriority health
    PolicyNeuroablation for Pain Management
    Policy CodePolicy 91647
    Change TypeCoverage stance updatescriteria additionsremovals
    Effective DateAug 1, 2026
    Last ReviewMay 13, 2026
    Next Review DateMay 13, 2026
    Key ActionObtain prior authorization demonstrating medical necessity (diagnostic blocks, conservative therapy, imaging) before neuroablative procedures.
    SourceLink
    POLICY UPDATE CHANGES

    Removed the prior limit of two RFA procedures per year and requirement for medical review beyond two.

    Conventional sacroiliac joint radiofrequency ablation moved from investigational to medically necessary when medical necessity criteria are met; Prior Authorization required.

    Updated investigational/experimental/uncertain status: cooled radiofrequency ablation remains investigational/uncertain for all indications except knee osteoarthritis.

    Added medical necessity criteria for repeat radiofrequency ablation for back and neck pain.

    Expanded not medically necessary to include nerve cryoablation and cryodenervation.

    New policy template standardization with Policy Scope, FDA/Regulatory, Medical/Professional Society Guidelines, and CMS sections.

    L3–S1Levels (BVN)
    ≥6 moConservative care (Intracept)
    50%Diagnostic block threshold
    ≥2Diagnostic medial branch blocks
    Removed prior numeric capAnnual cap
    E/I/UCooled RFA stance

    Coverage Criteria and Policy Stance

    Conventional RFA — initial

    Conventional Radiofrequency Ablation (RFA) for Back and Neck Pain is considered medically necessary when ALL of the following are met:

    Conventional RFA criteria: 1. Chronic axial back or neck pain predominating over radicular leg or arm pain, respectively; 2. Clinical presentation and diagnostic evaluation do not demonstrate another clear structural cause of the pain (e.g., disc herniation, spondylolisthesis, spinal stenosis); 3. No objective neurologic deficit on clinical exam; 4. Failed non-surgical conservative management; 5. Two diagnostic medial branch nerve blocks performed at the levels to be treated using a standardized protocol alternating long- and short-acting local anesthetics, with each block producing >50% improvement in pain consistent with the anesthetic used, confirming the facet joint as the pain generator.

    Repeat RFA — spine

    Repeat Radiofrequency Ablation for Back and Neck Pain is considered medically necessary when ALL of the following are met:

    Repeat RFA criteria: 1. Documentation demonstrates pain relief of at least 50% that lasted a minimum of 12 weeks; 2. A minimum of 6 months has elapsed since the prior radiofrequency ablation procedure; 3. Clinical findings and imaging studies exclude other obvious causes of axial pain (e.g., central spinal stenosis with neurogenic claudication/myelopathy; foraminal stenosis or disc herniation with concordant radicular pain that has been treated; infection; tumor; fracture; pseudoarthrosis; pain related to spinal instrumentation).

    Intraosseous Basivertebral Nerve RFA

    Intraosseous Basivertebral Nerve Radiofrequency Ablation is considered medically necessary when ALL of the following are met:

    Basivertebral nerve RFA criteria: 1. Target vertebral levels L3 through S1; 2. Individual is skeletally mature (≥18 years); 3. Chronic axial low back pain ≥6 months that has not responded to at least 6 months of conservative treatment (e.g., analgesics, anti-inflammatories, muscle relaxants, exercise, spinal manipulation, physical therapy or home exercise); 4. Lumbar MRI demonstrates Type 1 or Type 2 Modic changes at one or more vertebral endplates between L3 and S1 corresponding to treated levels; 5. No contraindications present (severe cardiac/pulmonary compromise; targeted ablation zone <10 mm from a sensitive structure such as the spinal canal; active systemic or localized infection; pregnancy; skeletally immature; presence of implantable pulse generators or other electronic implants).

    Sacroiliac joint RFA

    Sacroiliac (SI) Joint Radiofrequency Ablation is considered medically necessary when ALL of the following are met:

    SI joint RFA criteria: 1. Age ≥18 years; 2. Diagnosis of chronic SI joint–mediated pain supported by: localized posterior SI joint tenderness without similar tenderness elsewhere; a positive high thrust OR SI joint compression test; and at least two additional positive SI provocative tests (Gaenslen's, distraction, FABER, or posterior provocation); 3. Failed a minimum of 3 months of appropriate conservative management (e.g., physical therapy, pharmacologic therapy, activity modification); 4. Appropriate image-guided diagnostic blockade of the L5 primary dorsal ramus and sacral lateral branches (S1–S3) demonstrating ≥50% improvement in pain and function; 5. Clinical evaluation and/or imaging do not suggest another primary cause of pain (e.g., tumor, infection, inflammatory disease, osteoarthritis, neural compression).≥50% responder to diagnostic block

    Repeat SI joint RFA

    Repeat SI joint RFA is considered medically necessary when ALL of the following are met:

    Repeat SI joint RFA criteria: 1. Documentation demonstrates ≥50% reduction in pain with associated functional improvement; 2. A minimum of 12 weeks has passed since the previous ablation; 3. A minimum of 6 months has elapsed since the prior SI joint radiofrequency ablation procedure.≥50%

    Sacroiliac (SI) joint lateral branch RFA — medical necessity

    Covered when ALL of the following are met for conventional thermal SIJ lateral branch RFA:

    SIJ RFA coverage criteria: 1) Clinical suspicion of SIJ-mediated pain supported by positive SIJ provocation tests (multiple tests preferred); 2) Image-guided diagnostic blockade of the L5 dorsal ramus and S1–S3 lateral branches demonstrating ≥50% improvement in pain and function; 3) Failure of conservative management prior to RFA; 4) Procedure performed as conventional thermal lateral branch RFA under image guidance (fluoroscopy or CT).≥50% responder to diagnostic block

    Cooled RFA is considered not medically necessary/investigational; pulsed RFA is investigational and not medically necessary for any indication.

    Intracept (basivertebral nerve) RFA — medical necessity

    Covered when ALL of the following are met for Intracept BVN ablation:

    Intracept BVN ablation criteria: 1) Chronic low back pain duration ≥6 months; 2) Failure of at least 6 months of conservative nonsurgical care; 3) MRI demonstrating vertebral endplate changes consistent with Modic Type 1 or Type 2 changes (or described inflammatory/edema/endplate disruption features) corresponding to target levels; 4) Procedure performed targeting the basivertebral nerve at L3–S1 via an intraosseous/transpedicular approach under fluoroscopic guidance.≥6 months pain and conservative care

    Evidence includes randomized sham-controlled trials with mixed ITT/PP results and longer-term follow-up showing some durable improvements in subsets of patients.

    General medical necessity and plan applicability

    Coverage is conditional on medical necessity and member-specific benefit details.

    Plan and Medical Necessity Requirements: Coverage requires that the requested neuroablative procedure meets medical necessity as demonstrated in a prior authorization submission when applicable, and is consistent with the member's specific benefit plan or group-specific policy.

    If CMS has a Medicare determination, that governs Medicare members.

    Coverage stance updates

    Policy-level coverage stance changes and additions

    Conventional SIJ RFA: Conventional sacroiliac joint radiofrequency ablation is considered medically necessary when the policy's medical necessity criteria are met and prior authorization is obtained.

    Exact medical necessity criteria are located in other sections of the policy.

    Cooled RFA: Cooled radiofrequency ablation is considered investigational/experimental/uncertain for all indications except knee osteoarthritis (see Priority Health Medical Policy 91571).

    Requests for cooled RFA outside the knee OA exception are non-covered/deniable as investigational.

    Repeat RFA: Medical necessity criteria for repeat radiofrequency ablation for back and neck pain have been added; repeat procedures require meeting those criteria.

    Specific repeat procedure criteria are in other sections of the policy.

    The policy classifies cooled radiofrequency ablation (CRFA) (except when performed for knee osteoarthritis per a separate Priority Health policy) and cryoneurolysis/cryoneuroablation as not medically necessary/experimental or investigational for routine pain management. The rationale cites limited, heterogeneous evidence with short-term or inconsistent benefit and lack of standardized patient selection, procedural parameters, and durable long-term outcomes to support routine coverage outside established, indication-specific policies. (CRFA evidence is characterized by variable techniques, non-sham comparators, and absence of standardized diagnostic pathways; cryoneurolysis shows transient benefit in some settings with uncertainty about sustained outcomes.)

    Intercostal nerve cryoablation (INC) is explicitly described as a regional cryoanalgesia technique used for perioperative thoracotomy pain, but current evidence and major society guidance raise safety and long-term outcome concerns. Accordingly, intercostal nerve cryoablation is considered experimental, investigational, and/or unproven for routine management of post‑thoracotomy pain and is not supported for routine coverage.

    The policy maintains that pulsed radiofrequency ablation (PRF) is investigational and not medically necessary for any indication due to limited, inconsistent evidence, heterogeneous techniques, and lack of durable benefit. Separately, cooled RFA applied to the sacroiliac joint (cooled SIJ RFA) is considered not medically necessary/investigational when billed or reported as a cooled procedure because evidence does not demonstrate incremental clinical benefit over conventional thermal SIJ lateral branch RFA.

    When cooled RFA techniques are used for sacroiliac denervation, claims billed with the SIJ denervation code 64625 and reported as COOLED RFA are specifically not covered. Providers should report procedural codes consistent with conventional thermal RFA when criteria for covered SIJ lateral branch RFA are met; cooled-RFA reporting for SIJ denervation may be denied as not medically necessary.

    The policy explicitly expands exclusions to list nerve cryoablation and cryodenervation (examples include intercostal nerve cryoablation and other cryoanalgesia procedures) as not medically necessary. This expansion reflects the limited and heterogeneous evidence for durable benefit and aligns cryo-based peripheral nerve ablations with the investigational stance described elsewhere in the document.

    Across modalities, the evidence does not demonstrate consistent, durable clinical benefit sufficient for routine coverage: cooled RFA (outside knee OA) is limited by heterogeneity in patient selection, diagnostic protocols, and procedural technique with no standardized parameters or robust sham-controlled durability; pulsed RFA lacks reproducible, long-term improvements and standardized methods; and cryoneurolysis/cryoneuroablation generally shows only short‑term or perioperative analgesia with attenuation of benefit and uncertain longer‑term outcomes. For these reasons the policy treats these modalities as investigational/not medically necessary for routine pain management.

    Because pulsed RFA does not reliably produce neurodestructive lesions and existing studies are small, heterogeneous, and short-term, the policy concludes that pulsed radiofrequency ablation is not medically necessary for any indication. The limited and inconsistent evidence base and lack of guideline endorsement underpin this determination.

    Cooled sacroiliac joint RFA is considered investigational/not medically necessary because randomized and observational data have not demonstrated clear incremental benefit over conventional thermal SIJ lateral branch RFA. Operationally, claims for SIJ denervation billed with cooled-RFA technique (e.g., reported as COOLED RFA) may be denied; providers should follow conventional SIJ RFA coding and prior authorization requirements when applicable.

    Treatments classified as experimental, investigational, or unproven under this policy are excluded from coverage unless an individual case review is requested and prior plan approval is obtained. Such exception requests are adjudicated by a Priority Health medical director or clinical pharmacist and require submission of supporting clinical documentation demonstrating why the investigational approach may be appropriate for the specific member.

    The policy explicitly lists nerve cryoablation and cryodenervation (including intercostal nerve cryoablation) as not medically necessary. This exclusion is grounded in the limited durability of benefit, heterogeneity of evidence, and professional society guidance that does not endorse routine use of these cryo-based interventions for chronic pain indications.

    Coding and Billing

    ICD-10 Codes that may support medical necessityICD-10
    G89.21-G89.29Chronic pain, not elsewhere classified
    G89.3Neoplasm related pain (acute) (chronic)
    G89.4Chronic pain syndrome
    M54.03-M54.09Panniculitis affecting regions of neck and back
    M54.5-M54.9Other back pain
    M62.830Muscle spasm of back
    R52Pain, unspecified
    CPT/HCPCS Codesmixed
    22899Unlisted procedure, spine (used to report cooled radiofrequency ablation or Intracept when reported as unlisted)
    64999Unlisted procedure, nervous system (when used to report pulsed RFA for spinal pain)
    64620Destruction by neurolytic agent, intercostal nerve
    64624Destruction by neurolytic agent, genicular nerve branches including imaging guidance, when performed
    64625Radiofrequency ablation, nerves innervating the sacroiliac joint, with image guidance
    64628Thermal destruction of intraosseous basivertebral nerve, including all imaging guidance; first 2 vertebral bodies, lumbar or sacral
    64629Thermal destruction of intraosseous basivertebral nerve, including all imaging guidance; each additional vertebral body, lumbar or sacral
    64634Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance; cervical or thoracic, single facet
    64635Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance; cervical or thoracic, each additional facet joint
    64636Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance; lumbar or sacral, single facet joint
    1–10 of 14
    1/2
    Covered/Listed Procedural CPT Codes (selection shown)CPT
    22899Unlisted procedure, spine (when used to report cooled radiofrequency ablation or Intracept procedure)
    64999Unlisted procedure, nervous system (when used to report pulsed RFA for spinal pain)
    64620Destruction by neurolytic agent, intercostal nerve
    64624Destruction by neurolytic agent, genicular nerve branches including imaging guidance, when performed
    64625Radiofrequency ablation, nerves innervating the sacroiliac joint, with image guidance (Not covered when billed for COOLED RFA)
    64628Thermal destruction of intraosseous basivertebral nerve; first 2 vertebral bodies, lumbar or sacral
    64629Thermal destruction of intraosseous basivertebral nerve; each additional vertebral body, lumbar or sacral
    Cryoablation/Cryoneurolysis and Facet Neurolytic CodesCPT
    64634Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance; cervical or thoracic, single facet
    64635Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance; cervical or thoracic, each additional facet joint
    64636Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance; lumbar or sacral, single facet joint
    64640Destruction by neurolytic agent, lumbar or sacral, each additional facet joint
    0440TAblation, percutaneous, cryoablation, including image guidance; upper extremity distal/peripheral nerve
    0441TAblation, percutaneous, cryoablation, including image guidance; lower extremity distal/peripheral nerve
    0442TAblation, percutaneous, cryoablation, including image guidance; nerve plexus or truncal nerve (e.g., brachial plexus, pudendal nerve)
    HCPCS Device CodesHCPCS
    C9808Nerve cryoablation probe including probe and disposable system components (non-opioid medical device qualifying under section 4135 of the CAA, 2023)
    C9809Cryoablation needle including needle/tip and disposable system components (non-opioid medical device qualifying under section 4135 of the CAA, 2023)
    No explicit CPT/ICD codes in this extractmixed
    No codes listed
    inv-26: Diagnostic SIJ block responder threshold
    Diagnostic SIJ block responder threshold≥50% improvement in pain and function after image-guided diagnostic blockade of the L5 dorsal ramus and S1–S3 lateral branches
    Required documentationImage-guided diagnostic blockade results must demonstrate the ≥50% responder threshold prior to conventional SIJ lateral branch RFA consideration
    PurposeDiagnostic blocks are used to confirm SIJ-mediated pain and predict response to thermal lateral branch RFA
    inv-27: Annual RFA procedure cap — removed
    Prior numeric cap statusPrevious policy limit of two RFA procedures per year has been removed and is no longer applicable

    Provider Requirements, Prior Authorization, and Documentation

    Prior Authorization

    Prior authorization must demonstrate medical necessity (diagnostic blocks, conservative therapy, imaging)

    When prior authorization is required, submit documentation that demonstrates the requested neuroablative procedure meets medical necessity criteria — e.g., diagnostic block results meeting the policy responder thresholds (each medial branch or SIJ diagnostic block showing ≥50% pain relief), evidence of prior conservative therapy and its duration, and imaging excluding alternate structural causes.

    • Diagnostic blocks: two medial branch blocks with >50% pain relief for facet RFA; SIJ blockade showing ≥50% improvement in pain and function.
    • Conservative therapy: document trial and failure of appropriate non-surgical management (see conservative care callouts).
    • Imaging/clinical evaluation to exclude alternative causes (disc herniation, spinal stenosis, tumor, infection, etc.).
    Prior Authorization

    Prior authorization required when billing neuroablation CPT/HCPCS codes

    Prior authorization is required when billing the listed neuroablation CPT/HCPCS codes (e.g., 64625, 64628, 64629, 22899, 64999 and other codes in the policy) to confirm that the member meets the policy's medical necessity criteria.

    Required Conservative Therapy Before Intervention

    Documented trial and failure of conservative measures prior to procedure — minimum durations (6 months for basivertebral; 3 months for SI joint)

    Documented trial and failure of conservative measures prior to procedure — minimum durations:

    Conservative measures prior to basivertebral nerve RFA: At least 6 months of conservative nonsurgical care (e.g., analgesics, anti-inflammatories, muscle relaxants, exercise, spinal manipulation, physical therapy or home exercise programs) must have failed prior to consideration of intraosseous basivertebral nerve RFA.≥6 months
    Conservative measures prior to SI joint RFA: A minimum of 3 months of appropriate conservative management (e.g., physical therapy, pharmacologic therapy, activity modification) must have failed prior to consideration of sacroiliac joint RFA.≥3 months

    Documented failure of conservative therapies prior to neuroablation procedures as described — ≥6 months for Intracept; prior conservative management for SIJ RFA

    Procedure Frequency and Repeat Intervals

    inv-63: Repeat RFA timing thresholds
    Repeat spine RFA intervalMinimum of ≥6 months must have elapsed since the prior radiofrequency ablation procedure for repeat spine RFA consideration
    Repeat SI joint RFA - short intervalMinimum of 12 weeks since the previous SI joint ablation is required
    Repeat SI joint RFA - longer intervalA minimum of 6 months must have elapsed since the prior SI joint radiofrequency ablation procedure
    inv-64: No explicit frequency limits in provided chunks
    Frequency limits in extractNo explicit numeric frequency limits for many listed neuroablative CPT/HCPCS codes are specified in the provided chunks
    ImplicationPolicy does not include additional numeric per-procedure frequency caps in this extract beyond repeat-interval criteria

    Imaging and Procedural Guidance Requirements

    Documentation Required

    Lumbar MRI required for basivertebral nerve RFA

    For basivertebral (Intracept) and other neuroablative procedures, include lumbar MRI to document Modic Type 1 or 2 endplate changes and imaging to exclude other structural causes when submitting authorization or chart documentation.

    • MRI must show Modic Type 1 or Type 2 changes at treated levels for Intracept (L3–S1)
    • Imaging to exclude tumors, infection, or other structural causes should be provided when relevant
    Documentation Required

    Use fluoroscopy or CT for SIJ and Intracept procedures and diagnostic blocks

    Procedure and diagnostic blocks for SIJ lateral branch RFA and Intracept BVN ablation should be performed under image guidance (fluoroscopy or CT); include imaging modality in procedural notes and PA documentation.

    • State whether fluoroscopy or CT was used for diagnostic blocks and ablation
    • For Intracept, document fluoroscopic cannula placement and target levels (L3–S1)

    Excluded and Not Medically Necessary Procedures

    As a summarized ‘‘not covered’’ statement, cooled RFA (except knee osteoarthritis per separate policy), pulsed RFA, and cryoneurolysis/cryoneuroablation are classified as not medically necessary/experimental or investigational for routine pain management indications. The policy directs providers to the separate knee OA policy for the single exception and indicates that requests for these investigational modalities may be denied absent an approved individual case review.

    Intercostal nerve cryoablation and similar cryoanalgesia procedures are specifically called out among excluded techniques; routine use for post‑thoracotomy or other indications is considered experimental/investigational and therefore not covered under the policy.

    This slot lists additional investigational or not-covered neuroablative procedures per the policy's exclusions; refer to the full policy exclusions for the complete set of non-covered techniques and indications.

    This entry is reserved for other investigational or not-covered items as identified in policy updates and committee review; providers should consult the policy document for specifics.

    Placeholder for further non-covered procedures; see policy exclusions and coding sections for up-to-date statements about investigational techniques.

    Additional investigational or excluded procedures are enumerated in the policy's exclusions; clinicians should reference the policy for the definitive list.

    Reserved for future policy-noted investigational or not covered procedures; current exclusions include cooled RFA (outside knee OA), pulsed RFA, and cryoneurolysis.

    Definitions and Procedure Modalities

    inv-48: Conventional Radiofrequency Ablation definition
    DefinitionConventional radiofrequency ablation (RFA) is non-pulsed radiofrequency neurotomy that generates thermal lesions (approx. 60–90°C) to denervate target nerves and reduce pain
    MechanismRFA electrodes produce radiofrequency energy that generates heat (approx. 80°C) causing thermal destruction of target nerves
    Clinical noteEffects are temporary due to peripheral nerve regrowth; diagnostic nerve blocks are used to predict response prior to RFA
    inv-49: Cooled Radiofrequency Ablation (CRFA) definition and FDA clearance context
    DefinitionCooled radiofrequency ablation (CRFA) uses internally cooled probes to create larger, more uniform lesion volumes compared with conventional RFA
    Regulatory context

    Policy Revision Summary

    2026-05-13deletionLatest

    Removed the prior numeric limit of two RFA procedures per year and the associated requirement for medical review beyond two procedures.

    2026-05-13reclassification

    Conventional sacroiliac joint radiofrequency ablation reclassified from investigational/uncertain to medically necessary when medical necessity criteria are met; prior authorization required.

    2026-05-13

    Additional Notes and Placeholders

    Background: Neuroablative techniques attempt to interrupt pain transmission using thermal or cold-based approaches. Conventional RFA produces thermal lesions (roughly 60–90°C) intended to denervate target nerves, while variants such as cooled RFA use internally cooled probes to create larger lesion volumes and pulsed RFA delivers intermittent lower-temperature bursts for neuromodulation. Cryoneurolysis applies extreme cold to induce reversible axonal injury with time-limited analgesia. The policy's coverage positions reflect variability in the evidence base across these modalities, particularly concerns about long-term durability, standardized technique, and patient selection.

    Note

    Imaging guidance (fluoroscopy/CT) expected for diagnostic blocks and RFA

    Fluoroscopy or CT is expected for image-guided diagnostic blocks and RFA procedures as referenced across SIJ, facet, and intraosseous BVN sections; ensure procedural notes explicitly document the guidance modality.

    • Include fluoroscopic images or CT confirmation in the chart when available
    Policy Summary
    Payerpriority health
    PolicyNeuroablation for Pain Management
    Policy CodePolicy 91647
    Change TypeCoverage stance updatescriteria additionsremovals
    Effective DateAug 1, 2026
    Last ReviewMay 13, 2026
    Next Review DateMay 13, 2026
    Key ActionObtain prior authorization demonstrating medical necessity (diagnostic blocks, conservative therapy, imaging) before neuroablative procedures.
    SourceLink
    On This Page
    Coverage Criteria and Policy StanceCoding and BillingProvider Requirements, Prior Authorization, and DocumentationRequired Conservative Therapy Before InterventionProcedure Frequency and Repeat IntervalsImaging and Procedural Guidance RequirementsExcluded and Not Medically Necessary ProceduresDefinitions and Procedure ModalitiesPolicy Revision SummaryAdditional Notes and Placeholders
    Operational effectRemoval eliminates the prior requirement for medical review triggered after two procedures
    Provider actionDo not rely on an annual numeric cap of two RFA procedures for authorization decisions based on this extract
    • Include supporting clinical documentation with the PA (diagnostic block results, conservative care, imaging).
    • Report unlisted codes (22899, 64999) where applicable and include clinical justification per the PA submission.
    Note

    Prior authorization processes — consult Priority Health Provider Manual

    Follow the Priority Health Provider Manual and plan-specific prior authorization processes — some drugs, devices, services, or procedures may require PA and submission requirements vary by product.

    • Check the Provider Manual for required forms, submission channels, and timelines.
    • If individual case review is needed for investigational treatments, obtain prior plan approval.
    Prior Authorization

    Prior authorization required for conventional SIJ lateral branch RFA

    Conventional sacroiliac joint radiofrequency ablation now requires prior authorization when medical necessity criteria are met; submit a PA demonstrating the criteria for SIJ RFA have been fulfilled.

    • Document positive SIJ provocation tests and image-guided diagnostic block response (≥50% improvement in pain and function).
    • Include prior conservative management documentation and imaging excluding alternate causes.
    Step Therapy

    Conservative therapy must be documented before authorization

    Document a trial and failure of conservative therapy for the minimum durations specified by the policy before seeking authorization for neuroablative procedures.

    • Intracept (basivertebral nerve RFA): failure of at least 6 months of conservative nonsurgical care (analgesics, anti-inflammatories, muscle relaxants, exercise, spinal manipulation, physical therapy or home exercise).
    • SIJ RFA: failed minimum of 3 months of appropriate conservative management (physical therapy, pharmacologic therapy, and/or activity modification).
    Step Therapy

    Intracept requires ≥6 months of documented conservative nonsurgical care before consideration

    For Intracept (BVN ablation), at least six months of documented conservative nonsurgical care is required prior to consideration and submission for authorization.

    • Conservative care examples: analgesics, anti-inflammatory drugs, muscle relaxants, exercise, spinal manipulation, physical therapy, home exercise programs.
    • Include duration and specific therapies tried in the PA submission.
    Note

    Consult member-specific plan documents for coverage applicability

    Coverage is subject to the member's specific benefits and group-specific plan documents; consult the applicable plan documents as they supersede this policy when conflicts exist.

    • For self-funded (ASO) and individual policies, verify provisions in the member's plan document.
    • For Medicare members, CMS determinations govern when applicable.
    Billing Rule

    Removed prior numeric limit of two RFA procedures per year

    The prior numeric limit of two RFA procedures per year has been removed — do not use a 'two-per-year' cap as a basis for denial or review; continue to apply medical necessity and frequency-interval criteria for repeat procedures.

    • Apply repeat-procedure criteria (e.g., minimum intervals) rather than a numeric annual cap.
    • Document duration of prior benefit when requesting repeat RFA per repeat criteria.
    Documentation Required

    Required clinical documentation with PA: presentation, conservative therapy, diagnostic block details

    Submit detailed clinical documentation with PA or claim supporting medical necessity: the patient's presentation, prior conservative therapy and duration, results of diagnostic blocks including agents used and percent relief, and imaging excluding alternative causes.

    • For diagnostic blocks report the anesthetic agents used, timing, and percent pain relief (policy thresholds: >50% for medial branch blocks and ≥50% for SIJ blocks).
    • For repeat procedures document prior pain relief magnitude and duration (e.g., ≥50% relief lasting ≥12 weeks for repeat spinal RFA).
    Documentation Required

    SIJ lateral branch RFA — required documentation (provocation tests, diagnostic block ≥50%)

    For SIJ lateral branch RFA, include clinical exam findings (positive SIJ provocation tests), image-guided diagnostic blockade results showing ≥50% improvement in pain and function for L5 dorsal ramus and S1–S3 lateral branches, and documentation of prior conservative management.

    • List which provocative tests were positive (high thrust OR compression plus ≥2 additional tests such as Gaenslen's, distraction, FABER, posterior provocation).
    • Describe the image-guided block technique, agent(s) used, and the measured change in pain/function (≥50%).
    Documentation Required

    Intracept (BVN) authorization documentation: chronic LBP ≥6 months, failed ≥6 months conservative care, MRI Modic changes

    For Intracept BVN ablation requests, document chronic low back pain ≥6 months, failure of ≥6 months conservative nonsurgical care, lumbar MRI demonstrating Modic Type 1 or Type 2 endplate changes at target levels, and procedural plan including fluoroscopic intraosseous access to L3–S1.

    • Include MRI report(s) describing Modic Type 1 or Type 2 changes corresponding to treated vertebral levels.
    • Describe conservative therapies attempted, their durations, and lack of adequate response.
    Prior Authorization

    Submit PA requests with documentation proving medical necessity for initial or repeat RFA

    When prior authorization is required, submit the PA request with documentation that proves medical necessity and supports all required criteria for initial or repeat procedures; failure to provide required documentation or omission of PA when required may result in denial.

    • Include copies of diagnostic block records, conservative care notes, imaging reports, and procedure notes from prior RFA if requesting repeat ablation.
    • If the request involves an investigational technology, note that individual case review and prior plan approval are required for possible exception.
    Denial Risk

    Investigational technologies (cooled RFA, pulsed RFA, cryoneurolysis) — likely denial risk

    Requests for cooled RFA, pulsed RFA, or cryoneurolysis (including intercostal nerve cryoablation) will generally be denied as these are considered experimental, investigational, or not medically necessary per policy.

    • Cooled RFA is investigational for all indications except knee osteoarthritis (see separate knee OA policy No. 91571).
    • Pulsed RFA and cryoneurolysis/cryoablation (including INC) are listed as not medically necessary.
    Denial Risk

    Cooled SIJ RFA billed as cooled technique is not covered — denial risk

    Cooled SIJ RFA is considered not medically necessary/investigational; claims billed using the SIJ RFA code (64625) for a cooled RFA technique may be denied as not covered when billed as COOLED RFA.

    • If billing 64625, indicate the technique; cooled technique billed as cooled RFA is considered not medically necessary for SIJ.
    • For SIJ RFA coverage, procedure must be conventional thermal lateral branch RFA per policy criteria.
    Denial Risk

    Pulsed RFA is investigational and may be denied

    Pulsed radiofrequency ablation remains investigational and not medically necessary for any indication; requests billed as PRF may be denied.

    • PRF lacks standardized protocols and consistent durable benefit and therefore is excluded from coverage.
    • If requesting PRF, consider individual case review with prior plan approval only in exceptional circumstances.
    Note

    Individual case review with prior plan approval required for investigational treatments

    Experimental, investigational, or unproven treatments may be denied unless an individual case review with prior plan approval is obtained; all such decisions are made by a Priority Health medical director or clinical pharmacist.

    • Submit detailed clinical rationale and supporting evidence when requesting exception via individual case review.
    • Exceptions require prior plan approval before services are rendered to be considered for coverage.
    Denial Risk

    Cooled RFA (outside knee OA) classified investigational — denial risk

    Cooled radiofrequency ablation is classified as investigational/uncertain for indications other than knee osteoarthritis; requests for cooled RFA outside the knee OA exception may be denied as investigational.

    • Refer to Policy No. 91571 for the knee osteoarthritis exception.
    • Document clinical rationale if requesting an exception; consider individual case review.
    Denial Risk

    Denial risk if PA not obtained or criteria unmet for SIJ or repeat RFA

    Failure to obtain required prior authorization or failure to meet the policy's medical necessity criteria for conventional SIJ RFA or repeat RFA may result in claim denial.

    • Ensure PA includes diagnostic block results, provocation test findings, and documentation of conservative care.
    • For repeat SIJ RFA, include documentation of prior pain relief (≥50%), and the required minimum intervals (≥12 weeks since prior ablation and ≥6 months since prior SI joint RFA where applicable).
    Note

    Documented failure of conservative therapies prior to neuroablation procedures as described:

    Intracept prerequisite: Intracept BVN ablation is intended for patients with chronic low back pain of at least 6 months' duration who have failed at least 6 months of conservative nonsurgical care prior to consideration of the procedure.≥6 months
    SI joint RFA prerequisite: Sacroiliac joint RFA requires prior conservative management and image-guided diagnostic blockade demonstrating ≥50% improvement in pain and function before proceeding to RFA.≥50% responder to diagnostic block
    Provider actionRefer to full policy or prior authorization requirements for case-specific frequency guidance
    inv-65: Multiple neuroablative procedures listed; frequency limits not present
    Multiple procedures listedThe policy lists multiple neuroablative procedures and associated CPT/HCPCS codes (e.g., conventional RFA, cooled RFA, pulsed RFA, cryoablation, Intracept)
    Frequency limits absentSpecific per-procedure frequency limits beyond repeat-interval guidance are not present in these document portions
    Coding noteSome modalities (cooled RFA, pulsed RFA) are reported using unlisted CPT codes when applicable (e.g., 22899, 64999)
    inv-66: Radiofrequency ablation procedures (general) — prior annual limit removed
    Annual numeric limit removedThe prior numeric annual limit of two RFA procedures has been removed; no numeric annual limit is specified in this extract
    Policy changeDeletion explicitly removed the prior limit and associated review trigger
    Coverage implicationAuthorization decisions should follow medical necessity and repeat-interval criteria rather than an annual cap
    Documentation Required

    Perform facet, SIJ, and BVN RFA with fluoroscopy/CT when specified

    When the policy specifies imaging guidance for facet, SIJ denervation, or intraosseous BVN RFA, perform the procedure with fluoroscopy or CT and document the imaging used in the operative/procedure note.

    • Several CPT codes in the policy specify 'including imaging guidance' — reflect that in billing and documentation
    Documentation Required

    Document imaging guidance and diagnostic block results for SIJ/facet procedures

    Diagnostic blocks and subsequent RFA for SIJ and facet procedures are typically image-guided (fluoroscopy implied by policy references); record the imaging modality and the percent relief from each diagnostic block in the patient record.

    • Report block technique, agents used, imaging guidance, and measured percent pain/function improvement
    The Coolief® system is FDA-cleared for knee pain; CRFA use at other anatomic sites is off-label and remains investigational for most indications
    Evidence summaryHeterogeneous study designs and limited long-term durability across indications restrict conclusions about sustained benefit outside knee OA
    inv-50: Cryoneurolysis / Cryoanalgesia definition and evidence summary
    DefinitionCryoneurolysis/cryoanalgesia applies extreme cold via probes to produce reversible axonal injury that temporarily disrupts nerve conduction
    Evidence summaryAvailable trials show short-term pain and function improvements that are typically transient; long-term durability is uncertain and evidence is low to very-low certainty
    Safety/guideline noteProfessional societies have raised concerns about long-term outcomes in some settings (e.g., intercostal cryoanalgesia) and consider many cryo techniques investigational for chronic pain indications
    inv-51: Pulsed Radiofrequency (PRF) definition
    DefinitionPulsed radiofrequency (PRF) delivers short bursts of high-voltage RF energy at lower temperatures (~42°C) intended for neuromodulation without consistent neurodestruction
    Evidence summaryEvidence is limited, heterogeneous, and has not demonstrated consistent durable clinical benefit; standardized protocols and selection criteria are lacking
    Policy stancePRF is considered investigational and not medically necessary for any indication in this policy extract
    inv-52: Intercostal nerve cryoablation (INC) definition
    DefinitionIntercostal nerve cryoablation (INC) is a regional technique applying localized freezing to intercostal nerves to temporarily interrupt sensory conduction and reduce postoperative thoracotomy pain
    Policy stanceINC has demonstrated short-term reductions in acute postoperative pain but is considered experimental/investigational for routine post-thoracotomy pain due to potential for persistent chronic pain
    CodingIntercostal nerve cryoablation is associated with CPT code 64620 in the policy's code list
    inv-53: Pulsed radiofrequency ablation (PRF) — additional definition entry
    Definition (duplicate context)Pulsed radiofrequency ablation (PRF) delivers bursts of RF energy at lower temperatures (~42°C) to limit thermal injury and act via neuromodulation rather than neurodestruction
    Evidence noteStudies are small and short-term with inconsistent outcomes; PRF remains investigational per this policy
    Coding notePRF when reported for spinal pain may be billed using unlisted codes such as 22899 or 64999
    inv-54: Intracept Intraosseous Nerve Ablation System definition (L3–S1)
    Device/systemThe Intracept® Intraosseous Nerve Ablation System ablates basivertebral nerves at vertebral levels L3–S1 via a transpedicular cannula under fluoroscopic guidance
    Indication summaryIntended for chronic low back pain ≥6 months not responsive to ≥6 months of conservative nonsurgical care with MRI Modic Type 1 or 2 endplate changes
    Procedure stepsFluoroscopically guided pedicle cannula access, creation of a channel to BVN, insertion of RF probe, and thermal ablation of BVN
    inv-55: Cooled RFA / Pulsed RFA / Cryoneurolysis references in coding lists
    Coding referencesPolicy coding lists reference cooled RFA, pulsed RFA, and cryoneurolysis with specific CPT/HCPCS codes and unlisted-code usage where applicable (e.g., 22899, 64999, 0440T–0442T, C9808/C9809)
    ImplicationCoding lists note modality distinctions and device reporting conventions used in prior authorization and claims review
    Provider actionWhen reporting investigational modalities, appropriate unlisted codes or cryo-specific codes and device HCPCS should be used per policy guidance
    inv-56: Intraosseous Basivertebral Nerve RFA (Intracept) coding/definition notes
    Coding/definition noteIntraosseous basivertebral nerve RFA (Intracept) is represented by CPT 64628 (first two vertebral bodies) and 64629 (each additional vertebral body); unlisted spine code 22899 may also be used when applicable
    Target levelsProcedure targets basivertebral nerves at L3 through S1
    Evidence summaryRandomized sham-controlled trials and long-term follow-up are cited in support of the procedure for selected patients
    inv-57: Cryoablation / Cryodenervation definition and policy expansion to not medically necessary
    DefinitionCryoablation/cryodenervation refers to cold-based nerve ablation techniques that may cause irreversible tissue destruction at very low temperatures and are distinct from reversible cryoneurolysis
    Policy stance updateThe policy expanded not medically necessary listings to include nerve cryoablation and cryodenervation (examples include intercostal nerve cryoablation)
    Evidence summaryAvailable evidence shows short-term benefits in some contexts but lacks durable outcomes and raises safety concerns in certain settings; policy treats many cryo techniques as not medically necessary for chronic pain
    inv-58: Cooled radiofrequency ablation definition and investigational classification
    DefinitionCooled radiofrequency ablation uses cooled probes to create larger lesion zones compared with conventional RFA
    Policy classificationPolicy classifies cooled RFA as investigational/uncertain for most indications except knee osteoarthritis (see separate knee OA policy)
    Implication for coverageRequests for cooled RFA outside the knee OA exception may be denied as investigational
    coverage_update

    Cooled radiofrequency ablation status updated: remains investigational/experimental/uncertain for all indications except knee osteoarthritis (see related knee OA policy No. 91571).

    2026-05-13addition

    Added explicit medical necessity criteria for repeat radiofrequency ablation for back and neck pain.

    2026-05-13clarification

    Expanded not medically necessary/excluded list to explicitly include nerve cryoablation (e.g., intercostal nerve cryoablation) and cryodenervation; background and criteria language clarified.